03/25/2024 5:48 PM | Barbo William D (Reporting) Charles River Laboratories International (Issuer)
| Form 4/A | |
03/25/2024 5:52 PM | Charles River Laboratories International (Issuer) Parisotto Shannon M (Reporting)
| Form 4/A | |
03/25/2024 5:58 PM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4/A | |
03/25/2024 6:00 PM | Charles River Laboratories International (Issuer) Creamer Victoria L (Reporting)
| Form 4/A | |
03/25/2024 4:49 PM | Charles River Laboratories International (Issuer) Knell Michael Gunnar (Reporting)
| Form 4/A | |
03/25/2024 4:52 PM | Charles River Laboratories International (Issuer) Girshick Birgit (Reporting)
| Form 4/A | |
03/25/2024 4:55 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4/A | |
|
03/11/2024 3:42 PM | Charles River Laboratories International (Issuer) Knell Michael Gunnar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 1:34 PM | Charles River Laboratories International (Subject) Knell Michael Gunnar (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 3:54 PM | Charles River Laboratories International (Issuer) Knell Michael Gunnar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 11:47 AM | Charles River Laboratories International (Subject) Knell Michael Gunnar (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 4:37 PM | Charles River Laboratories International (Issuer) Creamer Victoria L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 2:14 PM | Charles River Laboratories International (Subject) Creamer Victoria L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 11:42 AM | Charles River Laboratories International (Subject) Parisotto Shannon M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 3:57 PM | Barbo William D (Reporting) Charles River Laboratories International (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 10:09 AM | Barbo William D (Reporting) Charles River Laboratories International (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 4:28 PM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:32 PM | Charles River Laboratories International (Issuer) Parisotto Shannon M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 5:37 PM | Charles River Laboratories International (Issuer) Girshick Birgit (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 10:02 AM | Charles River Laboratories International (Subject) LaPlume Joseph W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 8:19 AM | Charles River Laboratories International (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2024 7:31 PM | Charles River Laboratories International (Issuer) Kemps-Polanco Reshema (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:35 PM | Charles River Laboratories International (Issuer) Parisotto Shannon M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:14 PM | Charles River Laboratories International (Issuer) Girshick Birgit (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:34 PM | Charles River Laboratories International (Issuer) Girshick Birgit (Reporting)
| Form 4/A | |
01/31/2024 4:26 PM | Charles River Laboratories International (Issuer) Creamer Victoria L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:28 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:31 PM | Charles River Laboratories International (Issuer) Knell Michael Gunnar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:23 PM | Barbo William D (Reporting) Charles River Laboratories International (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:59 PM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:03 PM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 3:34 PM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/24/2024 1:27 PM | BlackRock Inc. (Filed by) Charles River Laboratories International (Subject)
| Form SC 13G/A | |
01/16/2024 3:32 PM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/11/2024 3:09 PM | Charles River Laboratories International (Issuer) Girshick Birgit (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 3:10 PM | Charles River Laboratories International (Subject) Creamer Victoria L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:10 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 11:36 AM | Charles River Laboratories International (Subject) LaPlume Joseph W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023 8:23 AM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 7:31 AM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
AI to Meet the Same Fate as EVs? (Ad) When these tech bubbles burst, they invariably leave investors disillusioned by their losses.
Now, many worry a similar fate is awaiting AI.
And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. |
11/09/2023 11:14 AM | Charles River Laboratories International (Subject) LaPlume Joseph W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023 8:06 AM | Charles River Laboratories International (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023 6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/29/2023 3:23 PM | Charles River Laboratories International (Issuer) WALLMAN RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 1:57 PM | Charles River Laboratories International (Subject) Knell Michael Gunnar (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023 12:54 PM | Charles River Laboratories International (Subject) LaPlume Joseph W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023 8:09 AM | Charles River Laboratories International (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/09/2023 6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/07/2023 3:37 PM | BlackRock Inc. (Filed by) Charles River Laboratories International (Subject)
| Form SC 13G/A | |
07/05/2023 2:29 PM | Charles River Laboratories International (Issuer) MACKAY MARTIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 2:31 PM | Charles River Laboratories International (Issuer) Knell Michael Gunnar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 9:22 AM | Charles River Laboratories International (Issuer) MACKAY MARTIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2023 5:10 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2023 3:17 PM | Charles River Laboratories International (Issuer) Knell Michael Gunnar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2023 12:18 PM | Charles River Laboratories International (Issuer) Creamer Victoria L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2023 12:21 PM | Charles River Laboratories International (Issuer) Parisotto Shannon M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2023 12:24 PM | Charles River Laboratories International (Issuer) Girshick Birgit (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2023 12:27 PM | Barbo William D (Reporting) Charles River Laboratories International (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2023 12:38 PM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 3:55 PM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 2:24 PM | Charles River Laboratories International (Issuer) Thompson Craig B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 2:27 PM | Charles River Laboratories International (Issuer) WILSON VIRGINIA M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 1:48 PM | Charles River Laboratories International (Issuer) REESE C RICHARD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 1:26 PM | Charles River Laboratories International (Issuer) Kochevar Deborah Turner (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 1:30 PM | Charles River Laboratories International (Issuer) Llado George Sr. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 1:43 PM | Charles River Laboratories International (Issuer) MACKAY MARTIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 1:46 PM | Charles River Laboratories International (Issuer) MASSARO GEORGE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 1:11 PM | Andrews Nancy C (Reporting) Charles River Laboratories International (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 1:23 PM | BERTOLINI ROBERT J (Reporting) Charles River Laboratories International (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2023 1:18 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 3:02 PM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2023 1:42 PM | Charles River Laboratories International (Issuer) MASSARO GEORGE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 1:49 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 1:20 PM | Charles River Laboratories International (Subject) LaPlume Joseph W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2023 1:51 PM | Charles River Laboratories International (Subject) LaPlume Joseph W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/11/2023 8:08 AM | Charles River Laboratories International (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023 6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2023 7:00 AM | Charles River Laboratories International (Filer)
| Form DEFA14A | |
03/30/2023 8:26 AM | Charles River Laboratories International (Filer)
| Form DEF 14A | |
03/30/2023 8:26 AM | Charles River Laboratories International (Filer)
| Form ARS | |